These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18769864)

  • 1. Levetiracetam in stiff-person syndrome.
    Sechi G; Barrocu M; Piluzza MG; Cocco GA; Deiana GA; Sau GF
    J Neurol; 2008 Nov; 255(11):1721-5. PubMed ID: 18769864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome.
    Rüegg SJ; Steck AJ; Fuhr P
    Neurology; 2004 Jan; 62(2):338. PubMed ID: 14745090
    [No Abstract]   [Full Text] [Related]  

  • 3. Levetiracetam for stiff-person syndrome: report of 2 patients.
    Shimberg WR; Patel NB; Sullivan KL; Hauser RA; Zesiewicz TA
    Clin Neuropharmacol; 2008; 31(5):301-2. PubMed ID: 18836351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stiff person syndrome.
    Ciccotto G; Blaya M; Kelley RE
    Neurol Clin; 2013 Feb; 31(1):319-328. PubMed ID: 23186907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
    Ben-Menachem E; Falter U
    Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A improves muscle spasms and rigidity in stiff-person syndrome.
    Liguori R; Cordivari C; Lugaresi E; Montagna P
    Mov Disord; 1997 Nov; 12(6):1060-3. PubMed ID: 9399238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.
    Shorvon SD; Löwenthal A; Janz D; Bielen E; Loiseau P
    Epilepsia; 2000 Sep; 41(9):1179-86. PubMed ID: 10999557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid onset of action of levetiracetam in refractory epilepsy patients.
    French J; Arrigo C
    Epilepsia; 2005 Feb; 46(2):324-6. PubMed ID: 15679515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
    Zesiewicz TA; Louis ED; Sullivan KL; Menkin M; Dunne PB; Hauser RA
    Mov Disord; 2004 Dec; 19(12):1518-21. PubMed ID: 15390069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study.
    Striano P; Coppola A; Vacca G; Zara F; Brescia Morra V; Orefice G; Striano S
    J Neurol; 2006 Jun; 253(6):762-6. PubMed ID: 16683063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam monotherapy for newly diagnosed epilepsy patients.
    Alsaadi TM; Thieman C
    Seizure; 2003 Apr; 12(3):154-6. PubMed ID: 12651080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of levetiracetam in Huntington disease.
    de Tommaso M; Di Fruscolo O; Sciruicchio V; Specchio N; Cormio C; De Caro MF; Livrea P
    Clin Neuropharmacol; 2005; 28(6):280-4. PubMed ID: 16340384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam monotherapy for elderly patients with epilepsy.
    Alsaadi TM; Koopmans S; Apperson M; Farias S
    Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.
    Kovács T; Farsang M; Vitaszil E; Barsi P; Györke T; Szirmai I; Kamondi A
    J Neural Transm (Vienna); 2009 Dec; 116(12):1631-4. PubMed ID: 19756367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal stiff-person syndrome.
    Fiol M; Cammarota A; Rivero A; Pardal A; Nogués M; Correale J
    Neurologia; 2001 Feb; 16(2):89-91. PubMed ID: 11257937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam in patients with central neuropathic post-stroke pain--a randomized, double-blind, placebo-controlled trial.
    Jungehulsing GJ; Israel H; Safar N; Taskin B; Nolte CH; Brunecker P; Wernecke KD; Villringer A
    Eur J Neurol; 2013 Feb; 20(2):331-7. PubMed ID: 22925226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome.
    Brown P; Thompson PD; Rothwell JC; Day BL; Marsden CD
    Mov Disord; 1991; 6(1):73-5. PubMed ID: 2005926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label pilot study of levetiracetam for essential tremor.
    Ondo WG; Jimenez JE; Vuong KD; Jankovic J
    Clin Neuropharmacol; 2004; 27(6):274-7. PubMed ID: 15613931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.